Dinesh R. Khokal, PhD

Prior to Amgen, Dinesh held the role of Director of Therapeutic Products Branch at the Singapore Medicine Regulatory Agency, Health Sciences Authority (HSA). During his 10 years tenure in HSA, his main role was to manage, oversee and drive the key development, review, licensure and administer the pre-market regulatory framework for western medicines covering innovative drugs, generics, biologics including, biotherapeutics, vaccines, combination products and biosimilars. He has also played several key roles in multiagency consortiums and WHO initiatives working towards capability building, shaping regulatory landscape, regulatory harmonisation and mutual reliance.

Prior to the roles in the regulatory agency, Dinesh held many positions in Biopharmaceutical and Medical Device industries as well as in Academia for over 20 years.

Dinesh received his Ph.D. in Cell and Molecular Biology from the National University of Singapore. He is an American Society for Quality Certified Quality Auditor and Biomedical Auditor. He has also earned certifications in Clinical Trials Management and Healthcare Policy and Governance.

Dinesh is the immediate past President of PDA Singapore Chapter and he is currently on the PDA Regulatory Affairs and Quality Advisory Board (RAQAB). Dinesh has been a frequent speaker at PDA events in Asia-Pacific.